THOUSAND OAKS, Calif. , Dec. 10, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.38 per share dividend for the first quarter of 2025. The dividend will be paid on March 7, 2025 , to all stockholders of record as of the close of business on February 14, 2025 . About Amgen Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today. Amgen is advancing a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers" by Forbes, among other external recognitions . Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average ® , and it is also part of the Nasdaq-100 Index ® , which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization. For more information, visit Amgen.com and follow Amgen on X , LinkedIn , Instagram , TikTok , YouTube and Threads . Forward-Looking Statements This news release contains forward-looking statements that are based on the current expectations and beliefs of Amgen. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including any statements on the outcome, benefits and synergies of collaborations, or potential collaborations, with any other company (including BeiGene, Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio, Inc., ChemoCentryx, Inc., or Horizon Therapeutics plc (including the prospective performance and outlook of Horizon's business, performance and opportunities, any potential strategic benefits, synergies or opportunities expected as a result of such acquisition, and any projected impacts from the Horizon acquisition on our acquisition-related expenses going forward), as well as estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes, effects of pandemics or other widespread health problems on our business, outcomes, progress, and other such estimates and results. Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission reports filed by Amgen, including our most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and current reports on Form 8-K. Unless otherwise noted, Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise. No forward-looking statement can be guaranteed and actual results may differ materially from those we project. Our results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments involving current and future products, sales growth of recently launched products, competition from other products including biosimilars, difficulties or delays in manufacturing our products and global economic conditions. In addition, sales of our products are affected by pricing pressure, political and public scrutiny and reimbursement policies imposed by third-party payers, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends toward managed care and healthcare cost containment. Furthermore, our research, testing, pricing, marketing and other operations are subject to extensive regulation by domestic and foreign government regulatory authorities. We or others could identify safety, side effects or manufacturing problems with our products, including our devices, after they are on the market. Our business may be impacted by government investigations, litigation and product liability claims. In addition, our business may be impacted by the adoption of new tax legislation or exposure to additional tax liabilities. If we fail to meet the compliance obligations in the corporate integrity agreement between us and the U.S. government, we could become subject to significant sanctions. Further, while we routinely obtain patents for our products and technology, the protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, or we may fail to prevail in present and future intellectual property litigation. We perform a substantial amount of our commercial manufacturing activities at a few key facilities, including in Puerto Rico , and also depend on third parties for a portion of our manufacturing activities, and limits on supply may constrain sales of certain of our current products and product candidate development. An outbreak of disease or similar public health threat, such as COVID-19, and the public and governmental effort to mitigate against the spread of such disease, could have a significant adverse effect on the supply of materials for our manufacturing activities, the distribution of our products, the commercialization of our product candidates, and our clinical trial operations, and any such events may have a material adverse effect on our product development, product sales, business and results of operations. We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to collaborate with or acquire other companies, products or technology, and to integrate the operations of companies or to support the products or technology we have acquired, may not be successful. There can be no guarantee that we will be able to realize any of the strategic benefits, synergies or opportunities arising from the Horizon acquisition, and such benefits, synergies or opportunities may take longer to realize than expected. We may not be able to successfully integrate Horizon, and such integration may take longer, be more difficult or cost more than expected. A breakdown, cyberattack or information security breach of our information technology systems could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business and operations may be negatively affected by the failure, or perceived failure, of achieving our environmental, social and governance objectives. The effects of global climate change and related natural disasters could negatively affect our business and operations. Global economic conditions may magnify certain risks that affect our business. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all. CONTACT: Amgen, Thousand Oaks Elissa Snook , 609-251-1407 (media) Justin Claeys , 805-313-9775 (investors) View original content to download multimedia: https://www.prnewswire.com/news-releases/amgen-announces-2025-first-quarter-dividend-302328180.html SOURCE Amgen
Chelsea Football Club is currently the hottest team in the English Premier League, with their scintillating attacking display leaving fans in awe. After their latest victory, the team took the time to thank their loyal supporters, who have been instrumental in their success.
MARPAI ANNOUNCES GENERAL UPDATES FOR Q4
We are finally winding down another year and yet again we find ourselves on a renewed quest to improve our lives. Before we set the big holidays behind us, let’s welcome positivity and set intentions for the year ahead. Conclude 2024 with a grateful heart and reflect on how we can make life easier and more intentional for the coming year. Small improvements such as refining routines or creating spaces that truly support your lifestyle can set the pace for a smarter, and more rewarding year ahead. Here, we’ve gathered some hacks and smart home items for the most-visited rooms. To those who want to start fresh. Making simple but thoughtful upgrades can create a space that not only works harder for you but also inspires a sense of ease and purpose as you move into 2025. A Smarter Kitchen The kitchen is the hub of activity in any home, and smart upgrades can make it more efficient and enjoyable. Start with the Franke Onyx Two Built-In Induction Hob , perfect for small spaces with its sleek design and precision cooking capabilities. Pair it with the Hamden Range Hood Touch Control to maintain a clean, odor-free environment while adding a modern aesthetic. These appliances combine form and function, making your kitchen work smarter while looking its best. Bathrooms with a Twist Make the most of your bathroom experience with products that blend innovation and comfort. The GROHE Euphoria 180 Shower System delivers a luxurious shower while conserving water, and the GROHE Smartcontrol Trimset Shower Mixer lets you customize every detail for an optimized experience. For the ultimate upgrade, the Kohler Veil Intelligent Toilet is a standout with its automated features and space-saving design, redefining what it means to have a modern bathroom. Comfort Meets Smart in Living Spaces Your living room and bedroom deserve the same level of attention when it comes to comfort and functionality. The Heim Mattress offers a perfect balance of comfort and adaptability. It is designed with innovative foam technology to cater to your body’s comfortability. Choose from standard, deluxe, or premium options—all crafted to provide maximum relaxation and peace of mind. The Heim Mattress is also made with memory foam free from harmful compounds. This attention to detail allows you to recharge in a safe and health-supporting environment. Complement this comfort with the Alphalux Radiant Series 5-star rated LED bulb. It is known for its exceptional brightness, long-lasting performance of up to 25,000 hours, and cost-saving efficiency. You can light up any space in your home with Alphalux. Smart Solutions for Every Room No smart home is complete without efficient essentials like the ARISTON Water Heater . Compact and energy-conscious, it provides instant hot water for your bathroom or kitchen needs. These products aren’t just upgrades—they’re investments in a smarter, more convenient future. Start 2025 Smarter Make 2025 the year of smarter living. A smart home isn’t just about adding technology to your homes. It is also about creating spaces that seamlessly fit your lifestyle and make daily routines effortless. With Wilcon Depot’s thoughtfully selected smart home solutions, upgrading to a more intuitive and efficient home has never been simpler. Visit Wilcon Depot and start your year with these smart additions to your home. Make 2025 the year of smarter living. For more information about Wilcon, visit www.wilcon.com.ph or follow their social media accounts on Facebook , Instagram , and Tiktok . or subscribe and connect with them on Viber Community , LinkedIn , and YouTube . Or you may contact Wilcon Depot Hotline at 88-WILCON (88-945266) for inquiries. Spotlight is BusinessWorld’s sponsored section that allows advertisers to amplify their brand and connect with BusinessWorld’s audience by publishing their stories on the BusinessWorld Web site. For more information, send an email to online@bworldonline.com . Join us on Viber at https://bit.ly/3hv6bLA to get more updates and subscribe to BusinessWorld’s titles and get exclusive content through www.bworld-x.com .
Shire's position on shark nets to be decided at crucial council meetingIn total, several individuals were transported to nearby hospitals for further evaluation and treatment. Medical personnel worked diligently to assess the patients' conditions and provide necessary care. Fortunately, most individuals responded well to treatment and were able to recover fully from their symptoms.As Geeks Knew It First, the pulse of the tech industry beats with anticipation, eager to witness the next wave of breakthroughs and revelations that will shape the world we live in. Stay tuned for more updates, insights, and revelations as we continue to delve into the vast expanse of technology and its limitless possibilities. The journey ahead is filled with excitement, challenges, and discoveries waiting to be unearthed. Embrace the unknown, explore the uncharted territories, and let your geek flag fly high as we embark on this exhilarating adventure together.
One of the most exciting aspects of the 2.2 update is the addition of new missions and quests. Players will have the opportunity to delve deeper into the intricate and immersive world of "2077," uncovering new mysteries and challenges along the way. These new missions will not only provide hours of gameplay but also add to the overall narrative of the game, allowing players to further immerse themselves in the cyberpunk universe.Daily Dose of Social Media: Matteo Berrettini’s heartfelt ‘Love Letter to Tennis’ and Jannik Sinner’s Dubai prepTrump crypto venture partners with platform linked to Middle East militants
By KAREEM CHEHAYEB BEIRUT (AP) — In 2006, after a bruising monthlong war between Israel and Lebanon’s powerful Hezbollah militant group, the United Nations Security Council unanimously voted for a resolution to end the conflict and pave the way for lasting security along the border. But while there was relative calm for nearly two decades, Resolution 1701’s terms were never fully enforced. Now, figuring out how to finally enforce it is key to a U.S.-brokered ceasefire deal approved by Israel on Tuesday. In late September, after nearly a year of low-level clashes , the conflict between Israel and Hezbollah spiraled into all-out war and an Israeli ground invasion . As Israeli jets pound deep inside Lebanon and Hezbollah fires rockets deeper into northern Israel, U.N. and diplomatic officials again turned to the 2006 resolution in a bid to end the conflict. Years of deeply divided politics and regionwide geopolitical hostilities have halted substantial progress on its implementation, yet the international community believes Resolution 1701 is still the brightest prospect for long-term stability between Israel and Lebanon. Almost two decades after the last war between Israel and Hezbollah, the United States led shuttle diplomacy efforts between Lebanon and Israel to agree on a ceasefire proposal that renewed commitment to the resolution, this time with an implementation plan to try to bring the document back to life. What is UNSC Resolution 1701? In 2000, Israel withdrew its forces from most of southern Lebanon along a U.N.-demarcated “Blue Line” that separated the two countries and the Israeli-annexed Golan Heights, which most of the world considers occupied Syrian territory. U.N. peacekeeping forces in Lebanon, known as UNIFIL , increased their presence along the line of withdrawal. Resolution 1701 was supposed to complete Israel’s withdrawal from southern Lebanon and ensure Hezbollah would move north of the Litani River, keeping the area exclusively under the Lebanese military and U.N. peacekeepers. Up to 15,000 U.N. peacekeepers would help to maintain calm, return displaced Lebanese and secure the area alongside the Lebanese military. The goal was long-term security, with land borders eventually demarcated to resolve territorial disputes. The resolution also reaffirmed previous ones that call for the disarmament of all armed groups in Lebanon — Hezbollah among them. “It was made for a certain situation and context,” Elias Hanna, a retired Lebanese army general, told The Associated Press. “But as time goes on, the essence of the resolution begins to hollow.” Has Resolution 1701 been implemented? For years, Lebanon and Israel blamed each other for countless violations along the tense frontier. Israel said Hezbollah’s elite Radwan Force and growing arsenal remained, and accused the group of using a local environmental organization to spy on troops. Lebanon complained about Israeli military jets and naval ships entering Lebanese territory even when there was no active conflict. “You had a role of the UNIFIL that slowly eroded like any other peacekeeping with time that has no clear mandate,” said Joseph Bahout, the director of the Issam Fares Institute for Public Policy at the American University of Beirut. “They don’t have permission to inspect the area without coordinating with the Lebanese army.” UNIFIL for years has urged Israel to withdraw from some territory north of the frontier, but to no avail. In the ongoing war, the peacekeeping mission has accused Israel, as well as Hezbollah , of obstructing and harming its forces and infrastructure. Hezbollah’s power, meanwhile, has grown, both in its arsenal and as a political influence in the Lebanese state. The Iran-backed group was essential in keeping Syrian President Bashar Assad in power when armed opposition groups tried to topple him, and it supports Iran-backed groups in Iraq and Yemen. It has an estimated 150,000 rockets and missiles, including precision-guided missiles pointed at Israel, and has introduced drones into its arsenal . Hanna says Hezbollah “is something never seen before as a non-state actor” with political and military influence. How do mediators hope to implement 1701 almost two decades later? Israel’s security Cabinet approved the ceasefire agreement late Tuesday, according to Prime Minister Benjamin Netanyahu’s office. The ceasefire is set to take hold at 4 a.m. local time Wednesday. Efforts led by the U.S. and France for the ceasefire between Israel and Hezbollah underscored that they still view the resolution as key. For almost a year, Washington has promoted various versions of a deal that would gradually lead to its full implementation. International mediators hope that by boosting financial support for the Lebanese army — which was not a party in the Israel-Hezbollah war — Lebanon can deploy some 6,000 additional troops south of the Litani River to help enforce the resolution. Under the deal, an international monitoring committee headed by the United States would oversee implementation to ensure that Hezbollah and Israel’s withdrawals take place. It is not entirely clear how the committee would work or how potential violations would be reported and dealt with. The circumstances now are far more complicated than in 2006. Some are still skeptical of the resolution’s viability given that the political realities and balance of power both regionally and within Lebanon have dramatically changed since then. “You’re tying 1701 with a hundred things,” Bahout said. “A resolution is the reflection of a balance of power and political context.” Now with the ceasefire in place, the hope is that Israel and Lebanon can begin negotiations to demarcate their land border and settle disputes over several points along the Blue Line for long-term security after decades of conflict and tension.
For Sassuolo, Sensi's contributions have been invaluable, and they will be hoping to continue benefiting from his talent for as long as possible. The club will be keeping a close eye on developments regarding Empoli's potential buyout, as they aim to secure Sensi's services for the long term.
AMGEN ANNOUNCES 2025 FIRST QUARTER DIVIDENDFurthermore, the 2.2 update will include a variety of quality-of-life improvements and bug fixes. CD Projekt Red has been listening to player feedback and has worked diligently to address issues and optimize gameplay experiences. Players can expect smoother performance, improved graphics, and enhanced overall gameplay quality with this update.